Fungal Mediator Tail Subunits Contain Classical Transcriptional Activation Domains by Liu, Zhongle & Myers, Lawrence C
Dartmouth College
Dartmouth Digital Commons
Open Dartmouth: Faculty Open Access Articles
2-2-2015






Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Medical Biochemistry Commons, and the Medical Molecular Biology Commons
This Article is brought to you for free and open access by Dartmouth Digital Commons. It has been accepted for inclusion in Open Dartmouth: Faculty
Open Access Articles by an authorized administrator of Dartmouth Digital Commons. For more information, please contact
dartmouthdigitalcommons@groups.dartmouth.edu.
Recommended Citation
Liu, Zhongle and Myers, Lawrence C., "Fungal Mediator Tail Subunits Contain Classical Transcriptional Activation Domains" (2015).
Open Dartmouth: Faculty Open Access Articles. 1320.
https://digitalcommons.dartmouth.edu/facoa/1320
Fungal Mediator Tail Subunits Contain Classical Transcriptional
Activation Domains
Zhongle Liu, Lawrence C. Myers
Department of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA
Classical activation domains within DNA-bound eukaryotic transcription factors make weak interactions with coactivator com-
plexes, such as Mediator, to stimulate transcription. How these interactions stimulate transcription, however, is unknown. The
activation of reporter genes by artificial fusion of Mediator subunits to DNA binding domains that bind to their promoters has
been cited as evidence that the primary role of activators is simply to recruit Mediator. We have identified potent classical tran-
scriptional activation domains in the C termini of several tail module subunits of Saccharomyces cerevisiae, Candida albicans,
and Candida dubliniensis Mediator, while their N-terminal domains are necessary and sufficient for their incorporation into
Mediator but do not possess the ability to activate transcription when fused to a DNA binding domain. This suggests that Media-
tor fusion proteins actually are functioning in a manner similar to that of a classical DNA-bound activator rather than just re-
cruiting Mediator. Our finding that deletion of the activation domains of S. cerevisiae Med2 and Med3, as well as C. dubliniensis
Tlo1 (a Med2 ortholog), impairs the induction of certain genes shows these domains function at native promoters. Activation
domains within coactivators are likely an important feature of these complexes and one that may have been uniquely leveraged
by a common fungal pathogen.
Despite years of study, the mechanism by which DNA-boundtranscriptional activators communicate this information to
the core transcription machinery in eukaryotes is unknown. Clas-
sical eukaryotic transcriptional activation domains (TADs) typi-
cally are found in sequence-specific DNA-bound transcription
factors that target coactivators (1), such as Mediator (2–4),
through weak interactions to stimulate the activity of the core
transcription machinery. The classical TAD is characterized by
lack of defined structure, and its weak interactions are thought to
facilitate the TAD touching multiple coactivator and core tran-
scription machinery targets (5). The 20 subunit Mediator co-
activator complex is a critical functional/physical intermediary
between DNA-bound activators and the general transcription ma-
chinery in all eukaryotes (4). Saccharomyces cerevisiae Mediator
(ScMediator) has structurally distinct modules, referred to as tail,
middle, head, and Cdk8 (3). S. cerevisiae tail module subunits
ScMed2, ScMed3, and ScMed15 stabilize each other’s presence in
the complex, facilitate interactions between DNA-bound tran-
scriptional activators and the complex at highly induced promot-
ers, and coordinate the activity of Mediator and other coactiva-
tors, such as the SAGA and Swi/Snf complex (3). Although it is
known that ScMed15 is a direct target for a variety of TADs (1), it
is not well understood how these weak TAD-Mediator interac-
tions mechanistically facilitate the action of the tail module and
Mediator to stimulate high levels of transcription. One idea is that
the interactions between DNA-bound TADs primarily serve to
physically recruit Mediator to certain promoters. Nonclassical ac-
tivators, in contrast to classical activators, are artificial constructs
covalently linking a DNA binding domain (DBD) to a component
of the transcription machinery, such as a Mediator subunit, that
have been used to test the recruitment hypothesis (5). The ability
of nonclassical activators, such as DBD fusions to Mediator sub-
units (i.e., Med2 and Med3), to affect upregulation of transcrip-
tion has been taken as the central evidence that physical recruit-
ment of Mediator to a specific promoter by the DBD is sufficient
for activation of a reporter gene, and that classical activators work
through a similar mechanism (6–8). A second important question
surrounding the fungal Mediator subunit Med2 involves its dis-
tant orthologs (9), referred to as Tlo proteins, in the human fungal
pathogens Candida albicans and Candida dubliniensis.
The TLO (for telomere localized) genes in C. albicans are
uniquely encoded by 14 highly identical paralogs versus only 2 Tlo
paralogs in the highly related but far less virulent fungal pathogen
C. dubliniensis. In all other sequenced fungi there is only one
Med2/Tlo ortholog and no clear orthologs in metazoan cells. Be-
cause the amplification of the C. albicans TLO genes is the most
striking difference from the highly syntenic C. dubliniensis ge-
nome, it has been postulated that it is an important factor in the
virulence of C. albicans (10, 11). Our recent finding that this am-
plification leads to a large population of free Tlo protein (in addi-
tion to the Mediator-associated form) in C. albicans (9) but not in
C. dubliniensis (12) has led us to investigate the functional prop-
erties that the Tlo/Med2 protein alone may possess that would
allow it to influence virulence.
Here, we report the presence of potent classical TADs in C.
albicans  and  clade Tlo (CaTlo), the C. dubliniensis Tlo
(CdTlo), and S. cerevisiae Med2 and Med3 proteins that are func-
tionally and physically separable from their incorporation into the
multisubunit complex. This finding suggests an alternative inter-
pretation of the DBD-Mediator subunit fusion experiments and
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leads us to conclude that the direct recruitment of Mediator to a
promoter is not sufficient for activated transcription. Our discov-
ery of Mediator-associated TADs also has important implications
for understanding how Mediator directs the activity of other co-
activators (13, 14) and how the large excess of free Tlo protein in
C. albicans (9, 15) might affect virulence gene expression.
MATERIALS AND METHODS
Plasmid construction. The complete list of plasmids and primers used in
this study are available upon request. The details of the construction of
these plasmids is presented here. For the overexpression of the C. albicans
Tlo12C (CaTlo12C) and Med3-6His protein in Escherichia coli
cells, we modified the bicistronic plasmid pET21b-TLO12-MED3-6HIS
(9) to create pET21b-TLO12C-MED3-6HIS by amplifying the trun-
cated TLO12 using the primers LM032 and LM033, cleaving with BglII
and EcoRI, and cloning into a BglII/EcoRI-digested pET21b-TLO12-
MED3-6HIS backbone.
For expression of ScMed2 and ScMed3 fragments in S. cerevisiae, we
used a single-copy plasmid with the MED2 promoter followed by the
coding region for glutathione S-transferase– hemagglutinin (GST-HA)
fused to the N terminus of the Mediator fragment. The GST coding se-
quence from pGEX4T-1 was amplified by ZL212/ZL213 and inserted into
pGADT7 (Clontech) to replace GAL4AD between the KpnI and BglII sites
to create pADGST. A fragment that contained the ADH1 promoter and
coding sequence for GST followed by an HA tag was excised from
pADGST by NaeI/NdeI digestion and cloned into p415-BD. In the result-
ing vector, the ADH1 promoter was replaced by the ScMED2 promoter,
amplified by ZL220/ZL221, to generate pMEDGST. pMEDGST was di-
gested by NaeI and NdeI, and the PScMED2-GST-HA-containing fragment
was inserted into pCUP1-BD-ScMED2, -ScMED2N, and -ScMED2C
between the NaeI and NdeI sites to generate the corresponding
pMEDGST plasmids. pMEDGST-ScMED3, -ScMED3N, and
-ScMED3C were constructed by subcloning individual coding se-
quence-containing fragments from the corresponding pCUP1-BD plas-
mid into pMEDGST through NdeI and PvuI digestion.
For the one-hybrid assays in S. cerevisiae, we created a single-copy
plasmid in which the expression of the Gal4 DBD fusion protein to the
TAD candidate was driven by the S. cerevisiae CUP1 promoter in order to
mitigate the toxicity of strong TADs. The CUP1 promoter was chosen
since previous work had indicated that its activation was independent of
several important Mediator subunits (16). Our own work confirmed that
the levels of induction of a pCUP1-LacZ construct are equal within exper-
imental error for the mutant strains we used (data not shown). All CUG
codons in the C. albicans and C. dubliniensis genes fused to the Gal4 DBD
were changed to a universal serine codon. To construct plasmids for ex-
pression of Gal4 DBD fusion proteins in S. cerevisiae, the following pro-
cedure was followed. pGBKT7 (Clontech) was digested by EcoRV and
PvuII, and the 2,777-bp fragment was inserted into pRS314 cut at these
sites. The region between the two PvuI sites on this intermediate plasmid
(p314-BD), which contains the TRP1 marker, was replaced by its coun-
terpart from pRS415, which contains the LEU2 marker, to generate p415-
BD. The ScCUP1 promoter (17) was amplified by ZL121/ZL120 from
BY4742 genomic DNA, fused to part of the Gal4 DBD coding sequence
(amplified by ZL122/ZL123 from pGBKT7) by fusion PCR, and inserted
into p415-BD between the NaeI and XhoI sites to generate pCUP1-BD. To
create pCUP1-BD-ScMED2, -ScMED2N, and -ScMED2C, the coding
sequences for full-length ScMed2 (amino acids [aa] 1 to 431 amplified by
ZL214/ZL199), ScMed2 C terminus (aa 156 to 431, amplified by ZL198/
ZL199), and ScMed2 N terminus (aa 1 to 160, amplified by ZL214/ZL219)
were cloned into pCUP1-BD between the BamHI and NotI sites. The
coding sequence for full-length ScMed3 (aa 1 to 397, amplified by ZL245/
ZL246) was inserted into pCUP1-BD between the XmaI and SalI sites to
generate pCUP1-BD-ScMED3. Digestion of pCUP1-BD-ScMED3 with
NotI resulted in 2 fragments; the larger piece, which contained the vector
backbone and ScMed3 N terminus (aa 1 to 147) coding sequence, was
self-ligated to generate pCUP1-BD-ScMED3C, and the smaller piece,
which contained the ScMed3 C-terminal (aa 145 to 397) coding sequence,
was subcloned into pCUP1-BD through the NotI site in the correct ori-
entation to generate pCUP1-BD-ScMED3N. The coding sequence for
full-length CaTlo12 (aa 1 to 252) was obtained by digesting pET21b-
TLO12-MED3-6HIS by NdeI and EcoRI. The coding sequence for the
CaTlo12 N terminus (aa 1 to 166) was obtained by digesting pET21b-
TLO12C-MED3-6HIS (9) by NdeI and EcoRI. The coding sequence for
the CaTlo12 C terminus (aa 167 to 252) was amplified from pET21b-
TLO12-MED3-6HIS by ZL112/LM35 and digested by NcoI and EcoRI.
Each of these fragments first was cloned into pGBKT7 and then subcloned
into pCUP1-BD between the XhoI and NotI sites to generate pCUP1-BD-
CaTLO12, -CaTLO12C, and -CaTLO12N. ZL114/ZL115 were
used to amplify the coding DNA for the CaTlo5 C terminus (aa 120 to
176, identical to the C termini of CaTlo7, CaTlo11, and unspliced gene
product of CaTLO13) from C. albicans genomic DNA, and the PCR
product was inserted into p415-BD at the BamHI and NotI sites and
subcloned into the pCUP1-BD XhoI and NotI sites to generate pCUP1-
BD-CaTLO5N. DNA encoding aa 172 to 273 of CaTlo2 was amplified
by ZL116/ZL119 from C. albicans genomic DNA and fused with the frag-
ment amplified by ZL117/ZL118 from pCUP1-BD-TLO12N, which
encodes the remaining 14 amino acid residues of the Tlo2 C terminus
(FDNFDDFIGFDIND; conserved in CaTlo12) in frame with GAL4BD
by fusion PCR. The final product, which includes the coding sequence for
the entire CaTlo2 C terminus (aa 158 to 273), first was cloned into
p415-BD through the XhoI and NotI sites to generate p415-BD-
CaTLO2N. To change the CUG codon, which encodes CaTlo2
Ser239 in C. albicans, to a common serine codon (UCG), two overlapping
fragments containing the modified codon were amplified from p415-BD-
CaTLO2N by ZL117/ZL148 and ZL147/BDR, respectively, and sealed
by fusion PCR. This final PCR product was cloned into pCUP1-BD be-
tween the XhoI and NotI sites to generate pCUP1-BD-CaTLO2N. To
construct pCUP1-BD-CdTLO1N and pCUP1-BD-CdTLO2N, ZL131/
ZL132 and ZL192/ZL193 were used to amplify and clone CdTlo1N (aa
199 to 320) and CdTlo2N (aa 250 to 355) coding sequences, respectively,
from C. dubliniensis genomic DNA into the p415-BD vector. The CUG
codons of CdTlo1 (Ser280) and CdTlo2 (Ser322) were changed to UCG by
fusion PCR using ZL117/ZL146/ZL145/BDR and ZL117/ZL194/ZL195/
BDR, respectively, as previously described for the CaTlo2 Ser239 codon.
Each codon-modified DNA fragment was cloned into pCUP1-BD vector
between the XhoI and NotI sites. The WT VP16 activation domain and the
F442A mutant were amplified, with part of the GAL4 DBD, by ZL117/
ZL133 from pSB202 and its F442A derivative (18) and subcloned into
pCUP1-BD by XhoI and NotI. The full-length CaMed3 (aa 1 to 197),
CaMed3 C terminus (aa 107 to 197), and CaMed3 N terminus (aa 1 to
106) coding sequences were amplified from pET21b-TLO12-MED3-
6HIS (9) by ZL163/ZL256, ZL257/ZL256, and ZL163/ZL281, respectively,
and cloned into the BamHI and PstI sites of pCUP1-BD to generate
pCUP1-BD-CaMED3, -CaMED3N, and -CaMED3C. To fuse different
regions of the ScMed2 C terminus to the Gal4 DBD, DNA fragments
amplified by ZL198/ZL261, ZL260/ZL199, ZL198/ZL269 ZL260/ZL261,
and ZL270/ZL199, which encoded aa 156 to 385, 259 to 431, 156 to 268,
259 to 385, and 380 to 431, respectively, of ScMed2 from pCUP1-BD-
ScMED2 were individually cloned into the pCUP1-BD vector between the
BamHI and NotI sites. DNA products amplified by ZL198/ZL262 and
ZL263/ZL199 from pCUP1-BD-ScMED2 were sealed by fusion PCR and
cloned into the pCUP1-BD vector to generate CUP1-BD-ScMED2-A/B
for the expression of the Gal4BD-fused ScMed2 C terminus (aa 156 to 258
and 380 to 431), which lacks the N-rich domain. Coding DNA for ScMed3
C-terminal fragments aa 204 to 397, 204 to 346, and 145 to 203 was
amplified by ZL268/ZL246, ZL268/ZL296, and ZL266/ZL295, respec-
tively, from pCUP1-BD-ScMED3 and cloned into the pCUP1-BD vector.
pCUP1-BD-ScMED3-aa282-397 was the self-ligation product of NcoI-
digested pCUP1-BD-ScMED3. ZL297/ZL298 were used to amplify the
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genomic region that contains the sequence encoding the aa 375 to 397
fragment of ScMed3.
The integrating plasmids used to create the C. albicans one-hybrid
assay strains were constructed as follows. We replaced the CaACT1 pro-
moter in the integrating plasmid CIp-LexA (19), used to express the LexA
DBD-TAD fusion proteins in the C. albicans one-hybrid assay strains, by
the CaMAL2 promoter. The regulatable CaMAL2 promoter was used to
mitigate the toxicity of some constructs in the C. albicans reporter strain
cRC106 (19). Our earlier work has shown that the CaMAL2 promoter
functions independently of deletions in the Mediator tail module in C.
albicans (20). Specifically, the CaACT1 promoter in CIp-LexA (19) was
replaced by the CaMAL2 promoter by amplifying the CaMAL2 promoter
from pSFS2 (21) using ZL179/ZL180. This fragment was fused to the LexA
DBD coding sequence, which was amplified by ZL181/ZL182 from CIp-
LexA by fusion PCR. This pMAL2-LexA fragment was cloned into CIp-
LexA between the XhoI and MluI sites to generate the pMAL2-LexA vec-
tor. Various C. albicans and C. dubliniensis Tlo and Med3 fragments were
inserted into pMAL2-LexA between the MluI and PstI sites. Fragments
containing CaTLO12, CaTLO12N, and CaTLO12C were ampli-
fied by ZL168/ZL171, ZL169/ZL171, and ZL168/ZL189, respectively,
from pBSKS-TLO12 (9). TLO5N was amplified by ZL170/ZL172
from pCUP1-BD-CaTLO5N, CdTLO1N was amplified by ZL227/
ZL228 from C. dubliniensis genomic DNA, CaMED3N was amplified by
ZL255/ZL256 from C. albicans genomic DNA, and the CaGCN4 coding
sequence was excised from CIp-LexA-GCN4 (19) by MluI and PstI. All of
these DNA fragments were subcloned into pMAL2-LexA. The CaGCN4
coding sequence also was amplified by ZL229/ZL230 and subcloned into
pCUP1-BD between the BamHI and NotI sites for the reporter assays in S.
cerevisiae.
Vectors possessing DNA cassettes for integrating full-length CdTLO1,
CdTLO1C, and SAT1 marker (as the vector control) into the C. dublini-
ensis tlo strain at the original TLO1 locus were generated by inserting a
TLO1 downstream region amplified by ZL286/ZL287 into pFA6a-3HA-
SAT1 (9) between the Pme1 and SacII sites and then inserting the CdTLO1
open reading frame (ORF) with its upstream sequence (amplified by
ZL282/ZL299), CdTLO1C (encoding aa 1 to 200) with the upstream
sequence (amplified by ZL282/ZL300), or the upstream region itself (am-
plified by ZL282/ZL283) between the HindIII and AscI/BamHI sites. Sim-
ilarly, the same CdTLO1 downstream region and CdTLO1/CdTLO1C
coding region with the upstream sequence (amplified by ZL282/ZL284 or
ZL282/ZL285) were sequentially cloned into pFA6a-6HIS3FLAG-SAT1
for expressing the C-terminal 6His-3FLAG-tagged CdTlo1 or CdTlo1C
in the tlo strain.
Strain construction. The complete set of S. cerevisiae strains used in
this study is listed Table 1 and the complete set of Candida species strains
is listed in Table 2. The complete list of plasmids and primers used to
construct these strains is available upon request. For purification of C.
albicans Mediator containing Tlo12 or Tlo12C, we used C. albicans
strains (TLO12-6HIS-3FLAG and TLO12C-6HIS-3FLAG) with the
6HIS-3FLAG tag (9) integrated at the 3= end of the full-length or truncated
TLO12 (encoding aa 1 to 166) at the single chromosomal locus for
TLO12. A second set of C. albicans strains with an HA tag (9) integrated
at the 3= end of the full-length or truncated TLO12 (encoding aa 1 to 166)
and a 6HIS-3FLAG tag (9) integrated at the 3= end of MED8 was used to
purify Mediator via its head module. Specifically, C-terminal tagging of
CaMed8 and full-length CaTlo12 in C. albicans was performed as de-
scribed previously (9) in the BWP17 strain background (25). The primer
pair ZL113/KPP037 was used to amplify the TLO12C-3HA and
TLO12C-6HIS-3FLAG tagging cassettes from the pFA-3HA-ARG4
plasmid (27) and pFA-6HIS-FLAG-ARG4 plasmid (generated by replac-
ing the SAT1 marker in pFA-6HIS-FLAG-SAT1 [9] with the ARG4
marker), respectively. These cassettes were integrated into a single chro-
mosomal copy and validated as previously described (9).
To create the S. cerevisiae MED2 or MED3 C-terminal truncation
strains, BY4742 (Yeast Deletion Project [22]) was transformed by the
PCR products amplified by ZL217/ZL062 from pFA6a-KanMX6 (28) or
by ZL248/ZL250 from pFA6a-HIS3MX6 (28) to generate yLM148
(MED2C) or yLM149 (MED3C), respectively. The latter DNA product
also was used to replace the coding sequence of the Med3 C terminus with
a HIS3 marker in yLM148 to generate yLM150 (MED2C MED3C) and
in 13701 (med2 mutant; Yeast Deletion Project [22]) to generate an
intermediate strain. This intermediate med2 MED3C strain was triple
FLAG tagged on the 3= end of MED18 as described previously (29) to
generate yLM152. The procedure was used to triple FLAG tag the 3= end of
MED18 in 14393 (med3; Yeast Deletion Project [22]) to generate
yLM151. To generate yLM153 (med2 med3), the MED2 ORF was re-
placed with a KANr marker in 14393 using a PCR product amplified by
ZL218/ZL062 from pFA6a-KanMX6. yLM53 (med2/MED18-3FLAG)
was sporulated from a diploid strain resulting from mating MG107
(med2 [23]) and SHY349 (MED18-3FLAG [24]) and verified by the
inability to utilize galactose, which confirms the absence of MED2, and
immunoblotting to confirm the presence of FLAG-tagged MED18.
TABLE 1 List of S. cerevisiae strains used in this study
Strain Genotype Remarks Reference
BY4742 MAT his31 leu20 lys20 ura30 WT 22
13701 MAT his31 leu20 lys20 ura30 med2::KANr med2 22
14393 MAT his31 leu20 lys20 ura30 med3::KANr med3 22
yLM148 MAT his31 leu20 lys20 ura30 MED2::MED2C-KANr MED2C This study
yLM149 MAT his31 leu20 lys20 ura30 MED3::MED3C-HIS3 MED3C This study
yLM150 MAT his31 leu20 lys20 ura30 MED2::MED2C-KANr MED3::MED3C-HIS3 MED2C MED3C This study
yLM53 med2::TRP1 MED18::MED18-3FLAG-NATr med2 MED18-3FLAG This study; derived
from references
23 and 24
yLM151 MAT his31 leu20 lys20 ura30 med3::KANr MED18::MED18-3FLAG-NATr med3 MED18-3FLAG This study
yLM152 MAT his31 leu20 lys20 ura30 med2::KANr MED3::MED3C-HIS3
MED18::MED18-3FLAG-NATr
med2 MED3C MED18-3FLAG This study
yLM153 MAT his31 leu20 lys20 ura30 med2::HIS3 med3::KANr med2med3 This study
yLM246 MAT his31 leu20 lys20 ura30 MED7::MED7-3HA-HPH WT MED7-3HA This study
yLM247 MAT his31 leu20 lys20 ura30 MED17::MED17-3HA-HPH WT MED17-3HA This study
yLM248 MAT his31 leu20 lys20 ura30 MED2::MED2C-KANr MED3::MED3C-HIS3
MED7::MED7-3HA-HPH
MED2C MED3C MED7-3HA This study
yLM249 MAT his31 leu20 lys20 ura30 MED2::MED2C-KANr MED3::MED3C-HIS3
MED17::MED17-3HA-HPH
MED2C MED3C MED17-3HA This study
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To generate each strain (yLM158 to yLM165) for C. albicans one-
hybrid assays, pMAL2-LexA or the corresponding derivative was linear-
ized by StuI digestion before being transformed into cRC106 (19). Trans-
formants were selected on SC-uridine plates, and correct integration was
tested by PCR using ZL093/ZL174 and ZL173/ZL094.
To complement a C. dubliniensis tlo/ strain (12) with nontagged or
6HIS-3FLAG-tagged CdTLO1/CdTLO1C, individual integrative DNA
cassettes were released from the corresponding vector by HindIII and
SacII digestion and transformed into tlo cells by electroporation. The
correct integration was tested by ZL288/LM21 (for the 5= junction) and
KPP63/ZL289 (for the 3= junction) and Western blotting (anti-FLAG), if
applicable.
C-terminal tagging of Med7 and Med17 was done as described previ-
ously (29). Targeting DNA cassettes were amplified using pFA6a-3HA-
HPH (30) as the template, as well as primers ZL007/ZL008 for MED17
tagging and ZL043/ZL044 for MED7. Transformants were selected by
hygromycin B, and the correct integration was confirmed by both PCR
(KanB/ZL012 for MED17 tagging and KanB/ZL045 for MED7 tagging)
and Western blotting (anti-HA).
Protein purification. yLM53 (med2), yLM151 (med3), or yLM152
(med2 MED3C) strains carrying the indicated pMEDGST plasmid
were grown in SC-leucine liquid medium to late log phase and processed
as described previously (29, 31) with modifications. Whole-cell extract
(200 mg) was applied to 200 l anti-FLAG-M2 agarose (Sigma),
washed, and on-column treated by Benzonase [final concentration at 500
U/ml in 25 mM HEPES KOH (pH 7.6), 10% glycerol, 0.01% NP-40, 300
mM potassium acetate (KOAc), 2.5 mM magnesium acetate
{Mg(OAc)2}] (EMD) at room temperature for 30 min. Mediator complex
was eluted by 50 g/ml 3FLAG peptide.
Purification of Candida sp. Mediator complex was performed as de-
scribed previously (9). Expression, immobilized metal affinity chroma-
tography (IMAC) purification, and size-exclusion chromatography anal-
ysis of recombinant C. albicans Tlo12C/Med3-6His protein complex
were performed as described previously (9).
Liquid -gal assays. For S. cerevisiae -galactosidase (-gal) reporter
assays, the BY4742 strain was cotransformed with reporter plasmid with
multiple Gal4 binding sites, followed by the CYC1 core promoter fused to
LacZ (32) and a single-copy plasmid expressing a particular pCUP1-
driven Gal4BD fusion protein. Specifically, the BY4742 strain was
cotransformed with pLGSD5 (32) and the indicated plasmid expressing a
particular pCUP1-driven Gal4 DBD fusion protein. Transformants were
selected on SC-uracil-leucine plates. To determine the activation poten-
tial of a given fusion protein, at least 10 independent colonies from at least
two independent transformations first were grown overnight in 2 ml of
specified SC-uracil-leucine liquid medium, which contained 6.7 g/liter
yeast nitrogen base (YNB; without amino acids and with ammonium
sulfate; low Fe, Zn, Mn, Cu; US Biological), 2 g/liter dropout mix (syn-
thetic medium lacking adenine, histidine, leucine, tryptophan, and uracil,
without YNB) (US Biological), 2% glucose, 30 mg/liter adenine, 20 mg/
liter histidine, 20 mg/liter tryptophan, 200 g/liter FeCl3, 400 g/liter
ZnSO4 · 7H2O, 303 g/liter MnSO4 · H2O, and 800 nM CuSO4. Fresh
overnight cultures were diluted 1:20 in 3 ml of the same medium and
TABLE 2 List of C. albicans and C. dubliniensis strains used in this study
Strain Genotype Reference
BWP17 MTLa/ ura3::	imm434/ura3::	imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG 25
yLM154 MTLa/ ura3::	imm434/ura3::	imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG MED8::
MED8-6HIS-3FLAG-SAT1/MED8::MED8-6HIS-3FLAG-HIS1 TLO12::TLO12-3HA-ARG4/-a
This study
yLM155 MTLa/ ura3::	imm434/ura3::	imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG MED8::
MED8-6HIS-3FLAG-SAT1/MED8::MED8-6HIS-3FLAG-HIS1 TLO12::TLO12C-3HA-ARG4/-
This study
cZL1 MTLa/ ura3::	imm434/ura3::	imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG
TLO12::TLO12-6HIS-3FLAG-SAT1/-
9
yLM156 MTLa/ ura3::	imm434/ura3::	imm434 his1::hisG/his1::hisG arg4::hisG/arg4::hisG
TLO12::TLO12C-6HIS-3FLAG-ARG4/-
This study
cRC106 ura3::	imm434/ura3::	imm434 ade2::hisG/ade2::hisG::[pOPlacZ] 19






















Wü284 Candida dubliniensis wild type 26
tlo tlo1::FRT/tlo1::FRT; tlo2::FRTb 12
yLM250 tlo1::FRT/tlo1::SAT1; tlo2::FRT This study
yLM251 tlo1::FRT/tlo1::PTLO1-TLO1-SAT1; tlo2::FRT This study
yLM252 tlo1::FRT/tlo1::PTLO1-TLO1C-SAT1; tlo2::FRT This study
yLM253 tlo1::FRT/tlo1::PTLO1-TLO1-6HIS-3FLAG-SAT1; tlo2::FRT This study
yLM254 tlo1::FRT/tlo1::PTLO1-TLO1C-6HIS-3FLAG-SAT1; tlo2::FRT This study
a In BWP17, one allele of TLO12 is missing due to a truncation event at the far right end of chromosome V. Therefore, BWP17, as well as its derivatives (yLM154, yLM155, cZL1,
and yLM156), contains only a single copy of TLO12 or its modified form.
b There is only one allele of TLO2 present in Wü284 and its derivatives due to a chromosomal truncation event.
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grown for 2 to 3 doublings. -Galactosidase activity was measured by the
SDS-chloroform method as described previously (23). Normally, reaction
mixtures were incubated in a 30°C water bath with shaking for 15 to 40
min to reach a final A420 reading in the range of 0.1 to 0.7. The optical
density at 600 nm (OD600) and A420 were determined by a Beckman
Coulter DU-7300 spectrophotometer.
To induce the activator fusion proteins in the C. albicans one-hybrid
experiments, the cells were grown in 2% maltose leading up to the mea-
surement of -gal activity. In C. albicans one-hybrid experiments, the
-galactosidase activity of each strain was based on measurements of at
least 5 independent PCR-verified transformants. Cells first were grown in
2 ml SC plus maltose (6.7 g/liter YNB [Difco], 2 g/liter synthetic dropout
mix lacking uracil [US Biological], 200 M uridine, and 2% maltose)
overnight and diluted 1 to 20 in 3 ml fresh SC plus maltose. After 2 to 3
doublings, -galactosidase activity was measured by the SDS-chloroform
method (23). The reaction time could be as long as 90 to 120 min to detect
weak -gal activities typically associated with this assay in C. albicans (19).




 OD600), where A420 is the absorbance of the
reaction product at 420 nm, T is the reaction time in minutes, OD600 is the
optical density at 600 nm of the cell resuspension used for the assay, and V
is the volume of the cell resuspension used for the assay in milliliters.
RT-qPCR. To test GAL gene induction in S. cerevisiae, a given strain
first was grown in SC plus raffinose (2%) overnight and diluted into fresh
SC plus raffinose. After 2 to 3 doublings, cells were collected and resus-
pended in SC plus galactose (2%). At 0 min, 20 min, or 90 min after
transfer to SC plus galactose, cultures were aliquoted and processed for
RNA preparation and reverse transcription-quantitative PCR (RT-qPCR)
as described previously (9). qPCR was performed and analyzed by the
relative standard curve method (Applied Biosystems). Specifically, the
relative standard curve of SCR1 was generated by series dilution of the
cDNA sample prepared from the WT cells at 0 min and used to determine
the relative abundance of SCR1 in all of the samples (1 to 100 diluted). The
relative standard curves for GAL1 and GAL10 were generated by series
dilution of the cDNA samples prepared from WT cells after 90 min of
galactose induction. Primers ZL241/ZL242, ZL243/ZL244, and ZL275/
ZL276 were used to quantify the relative mRNA abundance of GAL1,
GAL10, and SCR1, respectively.
GAL gene induction in C. dubliniensis was performed using an ap-
proach similar to that for S. cerevisiae. Cells were grown in SC plus glu-
cose/uridine instead of SC plus raffinose/uracil due to the incapability for
C. dubliniensis utilizing raffinose or uracil. The abundance of CdGAL1 and
CdGAL10 transcripts before and after induction (30 min in SC plus galac-
tose/uridine) were determined by RT-qPCR (primers ZL382/ZL383 for
CdGAL1 and primers ZL384/ZL385 for CdGAL10) with CdACT1 as the
reference.
Chromatin immunoprecipitation. Chromatin immunoprecipitation
(ChIP) experiments were performed as described previously (33), with
FIG 1 The N terminus of a C. albicans Tlo protein is necessary and sufficient for interactions with CaMed3 and incorporation into C. albicans Mediator. (A)
Coexpressed recombinant CaTlo12C and CaMed3-6His copurify by IMAC and size-exclusion chromatography. Lysates of E. coli cells coexpressing C. albicans
Tlo12C and Med3-6His protein were subjected to IMAC purification, and the eluates were further analyzed by size-exclusion chromatography (void volume,
7 ml; Superose 6). Input (Inp; IMAC eluate) and the fractions, which came off the column at the indicated elution volumes, were resolved by SDS-PAGE
(12.5%) and stained by Coomassie blue. (B and C) Affinity purification of Mediator from C. albicans strains with a tag placed on the C-terminal end of full-length
Tlo12 [TLO12-6HIS-3FLAG (cZL1)] or Tlo12C [TLO12C-6HIS-3FLAG(yLM156)] results in isolation of an intact complex as monitored by an
immunoblot demonstrating equal CaMed1 content (B) and by silver stain of the isolated complexes resolved by 10% SDS-PAGE (C). (D) Immunoblot showing
that a similar level of Tlo12-3HA and Tlo12C-3HA protein are present in CaMediator purified from the strains yLM154 and yLM155, respectively, using a
tag on the head module subunit Med8 (Med8-6His-3FLAG). Comparable amounts of anti-FLAG–agarose eluate (calibrated by FLAG signal; not shown) were
resolved by SDS-PAGE and probed by anti-HA and anti-CaMed1 antibody.
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modifications. yLM246, yLM247, yLM248, and yLM249 were grown
overnight in SC plus raffinose, diluted in fresh SC plus raffinose, and
allowed to experience 2 or 3 cell divisions before the culture was collected,
washed, and continued to grow in SC plus galactose for 90 min. After 20
min of cross-linking in 1% formaldehyde, the cells were lysed by five 20-s
bead beatings (Biospec). Crude chromatin samples first were probe son-
icated (Fisher) at 30% amplitude for three 8-s sonications and further
sheared by a Biodistruptor (high settings; 5 min four times; 30 s on/30 s
off). Cross-linked Mediator-chromatin complexes were immunoprecipi-
tated by F-7 HA antibody (Santa Cruz) and Dynabeads protein G (Life
Technologies). After reverse cross-linking, DNA was recovered by a PCR
purification kit (Qiagen). The recruitment pattern of Mediator along the
ScGAL1/10 locus was mapped by real-time PCR using primer pairs of
ZL436/ZL437, G2-F/G2-R, ZL410/ZL411, G4-F/G4-R, and ZL241/
ZL242. The enrichment of each DNA fragment was calculated by the
percentage of input recovered in the ChIP product and compared be-
tween strains after being normalized to the recovery (percent input) at
PMA1 promoter (by primers ZL462/ZL463). PMA1 is an actively tran-
scribed gene whose expression level is MED2/MED3 independent (34)
and whose promoter has a high constitutive occupancy of Mediator (35).
Growth assays. The indicated S. cerevisiae or C. dubliniensis strains
were grown overnight in YPD. After being washed in water, cells first were
diluted to 3 
 106 cells/ml, and diluted 1:10 into 3 
 102 cells/ml, and
spotted on YPD, YP plus 2% galactose plus 1 g/ml antimycin A (AA), or
YPD plus 5 mM H2O2 plates. Plates were incubated at 30°C. Liquid and
agar media for growing C. dubliniensis were supplemented with 0.1 mM
uridine.
Immunoblotting. Immunoblotting was performed as described pre-
viously (9, 29).
RESULTS
The N-terminal domains of S. cerevisiae Med3, S. cerevisiae
Med2, and C. albicans Tlo are necessary and sufficient for the
incorporation of these Mediator subunits into the complex. In
this work, we show that the C-terminal domains of the C. albicans
 and  clade (15) Tlo proteins, the C. dubliniensis Tlo proteins,
and S. cerevisiae Med2 (ScMed2) and Med3 (ScMed3) can serve as
potent transcriptional activation domains independently of their
incorporation into the Mediator complex. Although TADs do not
share any easily recognizable motifs or structures (36, 37), the C
termini of the  and  clade Tlo proteins do have a pattern of
acidic residues interspersed with hydrophobics that is character-
istic of acidic TADs (38). This observation, plus the potent ability
of full-length ScMed2 and ScMed3, compared to other Mediator
subunits, to activate a reporter gene when fused to the LexA DBD
(8) led us to hypothesize that the Tlo/Med2 and Med3 C termini
FIG 2 Ability of N- and C-terminal fragments of S. cerevisiae Med2 and Med3 to associate with Mediator. (A) The N termini of GST-Med2 and GST-Med3 fusion
proteins are necessary and sufficient for association with ScMediator complex purified from med2 MED18-3FLAG (yLM53) and med3 MED18-3FLAG
(yLM151) strains, respectively. Shown is an immunoblot comparing the composition of Mediator complex affinity purified from the med2 MED18-3FLAG
(yLM53) strain carrying pMEDGST-ScMED2-HA (lane1), pMEDGST-ScMED2N-HA (lanes 2 and 3), and pMEDGST-ScMED2C-HA (lane 4) and from the
med3 MED18-3FLAG (yLM151) strain carrying pMEDGST-ScMED3 (lane 5), pMEDGST-ScMED3N-HA (lanes 6 and 7), and pMEDGST-ScMED3C-HA
(lane 8) resolved by SDS-PAGE (10%) and probed by the indicated antibodies. The inability of the GST-ScMed2N and GST-ScMed3N proteins to associate
with the complex was not a result of reduced expression levels of the truncations (data available upon request). (B) The tail module of ScMediator can be stably
assembled and associated with the complex in the absence of the C termini of ScMed2 and ScMed3. Shown is an immunoblot comparing the composition of the
ScMediator complex purified from a med2 MED3C MED18-3FLAG strain (yLM152) expressing GST-HA-ScMed2 (lane 1) and GST-HA-ScMed2C (lane 2)
from the corresponding pMEDGST plasmid.
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were classical activation domains. We also hypothesized that the N
termini of these proteins were necessary and sufficient for the
association of these subunits with Mediator, and that the C-ter-
minal TAD activity was independent of incorporation into the
complex.
We determined how the N and C termini of Med2 (Tlo) and
Med3 contributed to the stability of the Mediator tail module
within the entire complex using a protein purification approach.
We divided the fungal Med2/Tlo and Med3 proteins, which form
a heterodimer within fungal Mediator complexes (9, 39), into N-
and C-terminal domains using a secondary-structure prediction
algorithm (PSIPRED). This analysis suggested that the N termini
consist of amphipathic -helices, which most likely interact to
form bundles with highly hydrophobic areas buried, and that the
C termini are unstructured. Coexpression of the N terminus of
recombinant C. albicans Tlo12, one of seven -clade Tlo pro-
teins that exist both as Mediator subunits and in a free form (9),
and C. albicans Med3 (CaMed3) in E. coli leads to the formation of
a cocomplex that is stable over several purification steps (Fig. 1A).
Consistent with the idea that the C termini of the Tlo proteins also
are dispensable for their incorporation into Mediator, the C ter-
minus of Tlo12 was not required for purification of intact Me-
diator from a C. albicans strain (TLO12C-6HIS-3FLAG) with
an affinity tag on the truncated Tlo subunit (Fig. 1B and C) or
from a C. albicans strain (MED8-6HIS-3FLAG) with an affinity
purification tag on a head module subunit (Fig. 1D). The C ter-
mini of ScMed2 and ScMed3 are similarly dispensable for their
incorporation into the S. cerevisiae complex. FLAG-agarose puri-
fication of Mediator from a S. cerevisiae med2 (or med3) strain,
which were FLAG tagged on the Med18 subunit and expressed the
N or C termini of ScMed2 (or ScMed3) fused to GST, showed that
only the N termini of these subunits were incorporated into an
intact complex (Fig. 2A). Purification of an intact ScMediator
from a FLAG-tagged med2 MED3C strain expressing GST-
HA-ScMed2C further shows that the tail module of the complex
can be stably assembled in the absence of the C termini of both
ScMed2 and ScMed3 (Fig. 2B). Having demonstrated that the C
termini of the Tlo proteins ScMed2 and ScMed3 were neither
necessary nor sufficient for association with their respective Me-
diator complexes, we sought to formally demonstrate that these
domains possessed potent TAD activity.
The C termini of S. cerevisiae Med3, S. cerevisiae Med2, C.
dubliniensis Tlo, and C. albicans  and  clade Tlo proteins are
potent transcriptional activation domains. We used one-hybrid
systems in S. cerevisiae (with constructs modified from reference
18) and C. albicans (19) to measure the activation potential of
various full-length, N-terminal, and C-terminal Med2(Tlo) and
Med3 fragments. The DNA binding domain fusion proteins were
under the control of an inducible promoter in both S. cerevisiae
(CUP1) (17) and C. albicans (MAL2) (21) to mitigate the toxicity
of potent activators and provide for comparable levels of fusion
protein expression among the constructs. Fusion of the full length
and C terminus of C. albicans Tlo12 to a heterologous DNA
binding domain (Gal4 DBD) led to high levels of activation of a
reporter in otherwise wild-type (WT) S. cerevisiae (Table 3) and C.
albicans (Table 4) strains, while the Gal4 DBD-C. albicans Tlo12
N-terminal fusion did not. The signal for the C terminus was
comparable to prototypical TADs in VP16 (36) and C. albicans
Gcn4 (19) (Tables 3 and 4). Akin to classical activation domains,
the C. albicans Tlo12 TAD is a potent activator in two distantly
related fungi. TAD activity was conserved in the C terminus of the
 clade C. albicans Tlo (Tlo2) and the C termini of the Tlo pro-
teins (CdTlo1 and CdTlo2) of the closely related human fungal
pathogen C. dubliniensis but not in the C terminus of a  clade C.
albicans Tlo (Tables 3 and 4). This finding represents the first clear
functional distinction between the highly expressed  and  clade
Tlo proteins and the far more weakly expressed (15)  clade Tlo
proteins. Despite virtually no sequence similarity (and an addi-
tional 200 amino acids), the C terminus of ScMed2 is also a
potent activator of transcription, while its Mediator-associated N
terminus is not (Table 3). We also have found a TAD in the C
terminus of ScMed3 (Table 3), which contains a polyglutamine
repeat. Polyglutamine repeats commonly overlap, and contribute
to, TAD activity (40–42). The C terminus of CaMed3, which does
not have polyglutamine repeats, does not possess TAD activity
TABLE 3 Activation by Gal4-Med2/Tlo fusions in S. cerevisiaea
Gal4 DBD fusion protein
(driven by pCUP1)
-Gal reporter activity
(Miller units, means  SDb)
Empty vector 5
CaTlo12 507  98
CaTlo12N 968  151
CaTlo12C 5
VP16 1,131  229
VP16 F442A 229  27
CaGcn4 941  149
CaTlo2N 324  53
CaTlo5N 5
CdTlo1N 1,109  268
CdTlo2N 1,431  198
ScMed2 63  17
ScMed2N 642  120
ScMed2C 5
ScMed3 736  110
ScMed3N 747  97
ScMed3C 32  10
CaMed3 38  7
CaMed3N 5
CaMed3C 44  11
a Using an S. cerevisiae one-hybrid system, the Gal4 DNA binding domain (DBD) was
fused to various S. cerevisiae, C. albicans, or C. dubliniensis Mediator gene fragments,
and the activation of a GAL4-CYC1-LACZ reporter was monitored. The TAD activities
of known classical activation domains (CaGcn4, VP16, and an attenuated VP16 mutant
[F442A]) also were measured as controls.
b SD, standard deviations.




(Miller units, means  SD)
Empty vector 0.9  0.1
CaTlo12 21.3  7.9
CaTlo12N 92.3  12.5
CaTlo12C 1.1  0.3
CaGcn4 8.9  1.6
CaTlo5N 0.7  0.1
CdTlo1N 155.1  36.0
CaMed3N 1.1  0.1
a Using the C. albicans one-hybrid system derived from the one developed by Russell
and Brown (19), we fused the LexA DNA binding domain N terminal to various
fragments of C. albicans and C. dubliniensis genes and monitored the activation of a
LEXA-ADH1-LACZ reporter.
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(Tables 3 and 4). While the polyglutamine repeats are required for
the TAD activity of the ScMed3 C terminus, the asparagine-rich
region in the ScMed2 C terminus actually appears to moderately
attenuate its TAD activity rather than facilitate it (Fig. 3). Inter-
estingly, the full-length Med2/Tlo fusions both were less active
than their C-terminal-only counterparts, suggesting some form of
autoinhibition. An increase in the TAD activity of full-length
Med2 fusions in strains lacking WT Med2 suggests incorporation
into Mediator may relieve this autoinhibition (Table 5). Interest-
ingly, a good portion of this increase appears to be attributable to
the presence of the ScMed3 TAD (Table 5). We also found that the
N terminus of ScMed3 and the N-terminal and full-length
CaMed3 possessed some weak activation potential in S. cerevisiae
(Table 3), despite the C terminus of CaMed3 having no activation
potential. This TAD activity appears to originate from the Med3 N
termini recruiting non-Mediator-bound free Med2/Tlo and its
associated TAD to the promoter, since the Med3 N-terminal TAD
activity is entirely dependent on the presence of the Med2 C ter-
minus (Table 5). Our findings and the published data (8) make it
likely that Med2 and Med3 possess the only potent activation do-
mains in S. cerevisiae Mediator, although previous work on S.
cerevisiae (8) suggests there is a weak TAD in Med15. It also is
possible that the DBD-Med15 fusion TAD activity observed in
that previous work (8) resulted from the recruitment of a small
amount of Med2/Med3/Med15 trimeric complex (43) that can
activate the reporter. Either of these scenarios also suggests an
alternative interpretation of earlier work showing that a mutation
in MED15, which enables a direct interaction with the Gal4 DBD
FIG 3 Subdomains of S. cerevisiae Med2 and Med3 C termini that contain TAD activity. (A) TAD activity in the ScMed2 C terminus resides within domain A
(aa 156 to 258) and domain B (aa 380 to 431), while the asparagine (N)-rich region that separates them appears to have an attenuating effect on the TAD activity
of domains A and B. -Galactosidase activities of various Gal4DBD-Med2 constructs were measured as described for Table 1. (B) Full TAD activity in the ScMed3
C terminus requires both glutamine-rich domains, Ala-Gln (aa 224 to 240) and Gln-Asn (aa 347 to 374), to be present. -Galactosidase activities of various
Gal4DBD-Med3 constructs were measured as described for Table 3.
TABLE 5 TAD activity of Med2 and Med3 in WT and mutant S. cerevisiae strains
Gal4 DBD fusion protein
(driven by pCUP1)
-Galactosidase reporter activitya (Miller units, means  SD)
WT med2 med2 MED3C med3 med3 MED2C
ScMed2 63  17 665  151 111  29 5 5
ScMed2N 642  120 404  54 426  82 395  85 507  66
ScMed2C 5 94  19 5 5 5
ScMed3 736  110 273  47 316  30 830  142 761  85
ScMed3N 747  97 291  43 398  52 358  71 365  36
ScMed3C 32  10 5 5 336  79 5
CaMed3 38  7 5 ND 687  121 10
CaMed3N 5 5 ND 5 ND
CaMed3C 44  11 5 ND 655  129 10
a Using an S. cerevisiae one-hybrid system, the Gal4 DBD was fused to various S. cerevisiae Med2 or Med3 domains, and the activation of a GAL4-CYC1-LACZ reporter was
measured in WT, med2, med2 MED3C, med3, and med3 MED2C strain backgrounds. ND, not determined.
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(no TAD), allowed the Gal4 DBD to activate a reporter gene with-
out its TAD (44). This result originally was interpreted as support-
ing the idea that the direct recruitment of Mediator was sufficient
for activated transcription (44). It is possible, however, that the
Gal4 DBD was recruiting a Mediator tail module subcomplex that
functioned as a classical TAD. The existence of potential TADs in
the remaining subunits of the C. dubliniensis and C. albicans Me-
diator is still an open question. Our characterization of TADs
conserved through divergent ascomycetes supports the idea that
the activated transcription previously observed in full-length Sc-
Med2 and ScMed3 fusions (8) is the result of a classical TAD rather
than a nonclassical one.
The Mediator-associated activation domains of S. cerevisiae
Med2 and Med3 are required for full induction of the GAL1,10
promoter. Med2 and Med3, in combination with the activator
target Med15, primarily positively regulate a subset of genes that
are highly induced in response to environmental stimuli in S.
cerevisiae (2). A function of the TADs associated with these sub-
units could be to amplify the signal of particular DNA bound
transcriptional activators by helping target other coactivator com-
plexes and increasing either the steady-state amount and/or in-
duction kinetics of certain transcripts. This idea is supported by
studies of S. cerevisiae showing the occupancy of the SAGA coacti-
vator complex at certain promoters can be interdependent with
(14) or dependent on (13) Mediator and its tail module subunits.
A recent study shows that Swi/Snf activity at the S. cerevisiae CHA1
promoter also is dependent on Mediator tail module subunits
(45). Consistent with such a scenario, we have found that the
TADs of ScMed2 and ScMed3 appear to function redundantly in
the induction of high levels of activated transcription. A pheno-
type associated with the individual deletion of ScMED2 or Sc-
MED3 is the inability to utilize galactose as a carbon source (23).
This phenotype directly correlates with gene expression defects in
the med2 and med3 strains (23). Individual deletion of the
TAD of ScMED2 (MED2C) or ScMED3 (MED3C) does not
have a pronounced effect (Fig. 4A) on this phenotype. However,
deleting both TADs (MED2C/MED3C) does lead to a growth
defect on galactose that is intermediate compared to the individ-
ual or combined deletion of MED2 and MED3 (Fig. 4A). Using
quantitative RT-PCR, we determined that an accompanying in-
FIG 4 Deletion of the C-terminal TADs of S. cerevisiae Med2 and Med3 affect GAL gene expression. (A) Series dilution growth assay testing the fitness of the
indicated med2 and med3 mutants on a YPD and YP galactose (supplemented with 2 g/ml antimycin A [AA]) plate. An S. cerevisiae strain lacking the C-terminal
TADs of both Med2 and Med3 (yLM150) has an intermediate growth defect using galactose as a carbon source compared to med2 (13701) (Yeast Deletion
Project), med3(14393), and med2/med3 (yLM153) strains. (B and C) RT-qPCR comparing the activation of GAL1 (B) and GAL10 (C) in the WT (BY4742)
and indicated mutant strains upon galactose induction. An S. cerevisiae strain lacking the C-terminal TADs of both Med2 and Med3 (yLM150) has an
intermediate defect in induction of the GAL1 (B) and GAL10 (C) genes upon shifting the carbon source from raffinose to galactose compared to a med2(13701)
strain. Each data point (means  standard deviations [SD]) represents, in total, five independent measurements from two independent biological replicates. The
med2, med3, and med2 med3 mutations all have comparable effects on induction of GAL1 and GAL10 (data available upon request). (D and E) Anti-HA
ChIP assays in wild-type and med2C/med3C strains with an HA tag on MED7 (D) or MED17 (E) show that the observed defect in GAL gene induction (B and
C) does not result from an inability of Gal4 to recruit Mediator to the GAL1,10 UAS upon shifting from raffinose (Raf) to galactose (Gal).
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termediate defect in transcriptional induction of the GAL genes
was present in the S. cerevisiae strain lacking the Med2 and Med3
TADs (Fig. 4B and C). Since previous data suggest the presence of
an additional TAD in ScMed15 (8), it is possible that there is
additional redundancy in the tail module that allows for these
intermediate levels of induction. Mediator occupancy, in a wild-
type strain, at the Gal4 binding site in the GAL1,10 promoter in-
creases dramatically when shifting the sole carbon source from
raffinose to galactose (46). To determine whether the removal of
the TADs influenced a pre- or post-Mediator occupancy step, we
performed a ChIP experiment at this locus using tagged middle
module (Med7)- and head module (Med17)-tagged strains (Fig.
4D and E). The overall pattern and enrichment of occupancy at
the UAS observed in the wild type is preserved in the mutant. This
indicates that the Med2 and Med3 TADs predominantly influence
a post-Mediator occupancy step in GAL1,10 induction. The
Med17 data show that there may be a slight decrease in Mediator
occupancy in the induced state. This could indicate that the TAD
mediates an interaction between coactivators (14) that facilitates
Mediator recruitment. Compared to that of S. cerevisiae, the single
TAD present in the C. dubliniensis Tlo1 subunit has a stronger
effect on the induction of a similar response.
The Mediator-associated activation domain of C. dublinien-
sis Tlo1 is required for response to carbon source and oxidative
stress. Of the two TLO genes in C. dubliniensis, TLO1 is expressed
at 50-fold higher levels than TLO2 under standard growth condi-
tions and can complement most phenotypes associated in a strain
with both deleted TLO genes (12). We tested the impact of the
Tlo-associated TAD in C. dubliniensis by removing the C-terminal
TAD in the only source of TLO1. Similar to S. cerevisiae and C.
albicans, purification of the C. dubliniensis Mediator showed that
the C-terminal TAD of Tlo1 was not necessary for its incorpora-
tion into an intact Mediator complex (Fig. 5). Complete deletion
of C. dubliniensis TLO1 and TLO2 results in the inability to grow
on galactose as its sole carbon source or under conditions of oxi-
dative stress (12). These phenotypes are complemented by ex-
pressing full-length TLO1 in the mutant strain (12). To test
whether the C-terminal TAD of Tlo1 was important for these
adaptive responses, we tried to complement these phenotypes
with the truncated Tlo1. TLO1C was only slightly better than the
mock vector control in its ability to grow on galactose and to
induce the C. dubliniensis GAL1 and GAL10 genes (Fig. 6A to C).
In addition, C. dubliniensis TLO1C also was unable to comple-
ment the oxidative stress susceptibility phenotype of the tlo dele-
tion mutant (Fig. 6D). These data lead us to speculate that the TLO
TADs in C. dubliniensis and C. albicans play a particularly impor-
tant role in adaptive responses in these pathogens.
DISCUSSION
This initial characterization of fungal Mediator-associated TADs
could have a broad impact on the understanding of important
areas in transcription regulation and fungal pathogenesis. The S.
cerevisiae Mediator tail module largely regulates SAGA-dependent
genes and helps direct the activity of the SAGA and Swi/Snf co-
activator complexes to specific promoters (13, 14, 45, 47). The
interaction of Mediator-associated activation domains with well-
characterized targets of certain DNA-bound transcriptional acti-
vators (1), such as Tra1 (48), could explain how Mediator coordi-
nates the recruitment of SAGA or other coactivators. Preliminary
mass spectrometry experiments probing proteins associated with
free C. albicans Tlo protein indicate that these interactions are
likely to be present. Experiments in which the activation of re-
porter genes result from the fusion of Mediator subunits to se-
quence-specific DNA binding domains (6–8), or the creation of a
new Mediator-DBD binding interaction (44), have been inter-
preted to suggest that direct recruitment of Mediator to promot-
ers, in the absence of a TAD, led to activated transcription. A
recent comprehensive study of nonclassical activators, however,
showed that only ScMed2 and ScMed3 had the capability to
strongly stimulate transcription when fused to a DBD in S. cerevi-
siae (8). Our finding that Med2/Tlo and ScMed3 possess TAD
activity that is separable from their incorporation into Mediator
suggests that mechanisms beyond recruitment are critical for a
TAD to stimulate the functionality of the complex. An interesting
unanswered question remains: why does the indirect targeting of
Mediator associated TADs to promoters by fusion of other Medi-
ator subunits to DBDs fail to activate transcription (8)?
Even though there are no clear metazoan MED2 and MED3
FIG 5 The N terminus of a C. dubliniensis Tlo1 protein is sufficient for incor-
poration into Mediator. (A and B) Affinity purification of Mediator from C. dub-
liniensis strains with a tag placed on the C-terminal end of full-length Tlo1 [TLO1-
6HIS-3FLAG (yLM253)] or Tlo1C [TLO1C-6HIS-3FLAG(yLM254)] results in
isolation of an intact complex as monitored by an immunoblot demonstrating
equal CdMed1 content (A) and by silver stain of the isolated complexes resolved by
10% SDS-PAGE (B).
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orthologs, Mediator-associated TADs likely are not restricted to
fungi and could themselves be a target of regulation. A domain
within the metazoan-specific Med25 tail module subunit appears
to have a TAD domain that targets CBP (49). Interestingly, the
presence of Mediator-associated TADs is associated with the tar-
geting of S. cerevisiae Med2 (8), Med3 (50), and the Arabidopsis
Med25 ortholog (51) by E3 ubiquitin ligases. There has been con-
siderable work showing that the targeting of classical DNA-bound
TADs by the ubiquitin proteasome system can potentiate or
downregulate their function depending on the specific TF and
context (52, 53). The targeting of Mediator-associated TADs by
this system could be a way that the cell signaling directly regulates
Mediator activity under certain conditions.
Lastly, a concept that is useful in envisioning how the large free
population of C. albicans Tlo protein (9) could affect transcrip-
tional regulation in the pathogen is “squelching.” Defined as the
downregulation of transcription by overexpression of a transcrip-
tional activator, presumably by sequestering activator targets off
chromatin, squelching has been demonstrated in artificial (54)
and a limited number of physiological (55) systems. The tran-
scriptional regulation of the C. albicans Tlo proteins in response to
pathways that impact pathogenesis (56, 57) suggests a novel role
for squelching in virulence gene expression, where the variation of
the free Tlo pool could up- or downregulate genes, which are
regulated by DNA-bound TADs that target the same coactivators.
Whether Med2 and Med3 expression is regulated in S. cerevisiae is
an open question. Recent proteomic quantification of abundance
puts Med2 and Med3 on the lower end compared to other Medi-
ator subunits (58). MED2 and MED3 generally are not affected in
S. cerevisiae genome-wide mRNA expression studies under differ-
ent conditions, although differences have been observed under a
limited number of circumstances (59). Differences in the expres-
sion of Mediator subunits impacting pathophysiology is not
unique to fungi. The expression of the human Mediator subunit,
Cdk8, is increased in 70% of colorectal cancer samples and is
significantly correlated with increased colon cancer-specific mor-
tality (60).
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